Department of Human Genetics, Amsterdam UMC, Amsterdam, the Netherlands; Amsterdam Reproduction & Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Department of Human Genetics, Amsterdam UMC, Amsterdam, the Netherlands; Amsterdam Reproduction & Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands; Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, the Netherlands.
Eur J Med Genet. 2024 Oct;71:104964. doi: 10.1016/j.ejmg.2024.104964. Epub 2024 Jul 26.
Weiss-Kruszka Syndrome (WSKA) is caused by pathogenic variants in ZNF462 representing a rare autosomal dominant congenital anomaly syndrome. It is characterized by global developmental delay, hypotonia, feeding difficulties, and craniofacial abnormalities, documented in fewer than 30 patients. ZNF462, located on chromosome 9p31.2, is a transcription factor and has an important role during embryonic development and chromatin remodelling. Here, we report three new patients with WSKA, Through whole exome sequencing (WES) analysis, we identified two novel variants in three patients, two of whom are siblings. These variants (c.3078dup, p.Val1027Cysfs5 and c.4792A > T p.Lys1598*) in the ZNF462 gene are likely resulting in haploinsufficiency. Our patients help to further delineate the phenotype, genotype and potential therapeutic management strategies for WSKA. Since we report a second WSKA patient with an autoimmune disease further clinical and functional studies are needed to elucidate the association between this chromatin remodelling disorder and the development of autoimmune problems. In the future, collaborative efforts are encouraged to develop an episignature for WSKA, given the gene's function and associated patient phenotypes. This new technology has the potential to provide valuable insights into the disorder.
Weiss-Kruszka 综合征(WSKA)是由 ZNF462 的致病性变异引起的,代表一种罕见的常染色体显性先天性异常综合征。它的特征是发育迟缓、张力减退、喂养困难和颅面异常,在不到 30 名患者中有记录。ZNF462 位于染色体 9p31.2,是一种转录因子,在胚胎发育和染色质重塑中具有重要作用。在这里,我们报告了 3 例新的 WSKA 患者,通过全外显子组测序(WES)分析,我们在 3 名患者中鉴定出 2 个新的变异,其中 2 名是兄弟姐妹。这些变异(c.3078dup,p.Val1027Cysfs5 和 c.4792A > T p.Lys1598*)在 ZNF462 基因中可能导致单倍不足。我们的患者有助于进一步描绘 WSKA 的表型、基因型和潜在的治疗管理策略。由于我们报告了第二例患有自身免疫性疾病的 WSKA 患者,因此需要进一步的临床和功能研究来阐明这种染色质重塑障碍与自身免疫问题发展之间的关系。未来,鼓励开展合作努力,为 WSKA 开发一个外显子签名,鉴于该基因的功能和相关患者表型。这项新技术有可能为该疾病提供有价值的见解。